Implantation of rotary blood pumps into 115 patients: A single-centre experience

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 6, 2013, Pages 1233-1236

  Meyer, Anna L ^a   Malehsa, Doris ^a   Bara, Christoph ^a   Haverich, Axel ^a   Strueber, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Heartmate II; Heartware; Left ventricular assist device; Outcome

Indexed keywords

ADULT; ARTICLE; BLOOD PUMP; CARDIAC IMPLANT; CARDIOVASCULAR MORTALITY; CENTRIFUGAL PUMP; CONTROLLED STUDY; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART GRAFT; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INOTROPISM; ISCHEMIC CARDIOMYOPATHY; LEFT VENTRICULAR ASSIST DEVICE; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; PRIORITY JOURNAL; SURGICAL MORTALITY;

HEARTMATE II; HEARTWARE; LEFT VENTRICULAR ASSIST DEVICE; OUTCOME;

ADULT; ANALYSIS OF VARIANCE; CARDIOMYOPATHIES; COHORT STUDIES; FEMALE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84878191263     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs568     Document Type: Article

References (16)

1. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-43.
2. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-51.
3. Patel ND, Weiss ES, Schaffer J, Ullrich SL, Rivard DC, Shah AS et al. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg 2008;86:832-40. discussion 832-40.
4. Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 2009;87:1072-8.
5. Haft J, Armstrong W, Dyke DB, Aaronson KD, Koelling TM, Farrar DJ et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 2007;116(11 Suppl):I8-15.
6. Strueber M, O'Driscoll G, Jansz P, Khaghani A, Levy WC, Wieselthaler GM. Multicenter evaluation of an intrapericardial left ventricular assist system. J Am Coll Cardiol 2011;57:1375-82.
7. Wieselthaler GM, O'Driscoll G, Jansz P, Khaghani A, Strueber M; HVAD Clinical Investigators. Initial clinical experience with a novel left ventricular assist device with a magnetically levitated rotor in a multi-institutional trial. J Heart Lung Transplant 2010;29:1218-25.
8. Sponga S, Ivanitskaia E, Potapov E, Krabatsch T, Hetzer R, Lehmkuhl H. Preoperative treatment with levosimendan in candidates for mechanical circulatory support. ASAIO J 2012;58:6-11.
9. Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007;116:497-505.
10. Demirozu ZT, Etheridge WB, Radovancevic R, Frazier OH. Results of HeartMate II left ventricular assist device implantation on renal function in patients requiring post-implant renal replacement therapy. J Heart Lung Transplant 2011;30:182-7.
11. Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg 2012; 144:584-603.
12. Popov AF, Hosseini MT, Zych B, Mohite P, Hards R, Krueger H et al. Clinical experience with HeartWare left ventricular assist device in patients with end-stage heart failure. Ann Thorac Surg 2012;93:810-5.
13. Kirklin JK, Naftel DC, Kormos RL, Stevenson LW, Pagani FD, Miller MA et al. The Fourth INTERMACS Annual Report: 4,000 implants and counting. J Heart Lung Transplant 2012;31:117-26.
14. Aaronson KD, Slaughter MS, Miller LW, McGee EC, Cotts WG, Acker MA et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation. Circulation 2012;125: 3191-200.
15. Meyer AL, Malehsa D, Bara C, Budde U, Slaughter MS, Haverich A et al. Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device. Circ Heart Fail 2010;3:675-81.
16. Slaughter MS, Naka Y, John R, Boyle A, Conte JV, Russell SD et al. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy. J Heart Lung Transplant 2010;29:616-24.